Table 4 Association between the use of PPI and maternal and neonatal outcomes presented as the odds ratio of having the outcome compared to non-users

1.21 (1.09–1.36)

1.24 (1.07–1.44)

1.11 (1.01–1.23)

1.00 (0.83–1.21)

1.31 (1.14–1.49)

0.81 (0.71–0.92)

1.30 (1.11–1.52)

1.35 (1.10–1.67)

1.56 (1.37–1.78)

1.07 (0.81–1.40)

1.19 (0.97–1.47)

0.85 (0.71–1.03)

1.05 (0.89–1.24)

1.32 (1.10–1.59)

1.19 (1.03–1.36)

1.19 (0.93–1.53)

1.28 (1.05–1.56)

0.87 (0.74–1.02)

1.34 (1.16–1.54)

1.38 (1.14–1.68)

1.06 (0.93–1.21)

1.02 (0.79–1.32)

1.14 (0.94–1.37)

0.82 (0.69–0.97)

1.41 (1.14–1.75)

1.29 (1.12–1.49)

1.01 (0.75–1.37)

1.29 (1.05–1.60)

0.92 (0.77–1.11)

1.23 (1.05–1.43)

1.14 (0.92–1.40)

1.16 (1.01–1.34)

0.96 (0.73–1.28)

1.45 (1.20–1.74)

0.79 (0.66–0.95)

1.01 (0.86–1.18)

1.26 (1.04–1.52)

1.45 (1.27–1.65)

1.24 (0.98–1.57)

1.25 (1.03–1.52)

0.83 (0.70–0.98)